Glendale, CANCT04661358Now EnrollingIRB Ready

Diabetic Retinopathy Clinical Trial in Glendale, CA

Access cutting-edge diabetic retinopathy treatment through this clinical trial at a research site in Glendale. Study-provided care at no cost to qualified participants.

Sponsored by Jaeb Center for Health Research

Quick Self-Assessment

See if you qualify for this Glendale location

Preparing your pre-screening questions...

Expert Care in Glendale

Access diabetic retinopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic retinopathy treatment provided free

Apply for This Glendale Location

Check if you qualify for this diabetic retinopathy clinical trial in Glendale, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Glendale

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Glendale site if eligible
  4. 4Begin participation

About This Diabetic Retinopathy Study in Glendale

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately severe non-proliferative DR (NPDR) and no CI-DME at baseline. In addition to evaluating efficacy, this study aims to evaluate the feasibility of a model for ophthalmologists to prescribe or collaborate with a primary care provider such as an internist/endocrinologist to prescribe and monitor the dru

Sponsor: Jaeb Center for Health Research

Who Can Participate

Inclusion Criteria

Age ≥18 years and \< 80 years.
Type 1 or type 2 diabetes.
At least one eye with the following:
Mild to moderately severe NPDR (defined by ETDRS DR severity level 35 to 47), confirmed by central Reading Center grading of fundus photographs.
Best-corrected E-ETDRS visual acuity letter score of ≥74 (approximate Snellen equivalent 20/32 or better). If best corrected letter score is 74-78, investigator must verify that vision loss is not due to the presence of CI-DME, cataract, or other condition that may affect visual acuity during the course of the study.
If only one eye is eligible, the non-study eye must have at least microaneurysms only (DR severity level 20) Key

Exclusion Criteria

Eye-level exclusion criteria (the eye is ineligible if any of the following is met):
Current CI-DME based on clinical exam or OCT central subfield thickness (CST)
Zeiss Cirrus: CST ≥290 µm in women or ≥ 305 µm in men
Heidelberg Spectralis: CST ≥305 µm in

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Glendale?

Yes, this clinical trial (NCT04661358) has an active research site in Glendale, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Retinopathy Treatment Options in Glendale, CA

If you're searching for diabetic retinopathy treatment options in Glendale, CA, this clinical trial (NCT04661358) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Glendale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic retinopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic retinopathy clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Glendale, CA

See all essential tremor clinical trials recruiting in Glendale — not just this study.

Browse Essential Tremor Trials in Glendale

Ready to Join in Glendale?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Glendale, CA